 | • レポートコード：B-GIR08C4013 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ニラパリブの世界市場について調べ、まとめました。種類別セグメントは、100mg * 30カプセル、100mg * 60カプセル、100mg * 90カプセル等、用途別セグメントは、再発上皮性卵巣癌、卵管癌、原発性腹膜癌、その他等に区分しました。ニラパリブの世界市場概観、企業動向、企業別ニラパリブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ニラパリブの市場概観 ・ニラパリブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ニラパリブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ニラパリブの世界市場規模 ・ニラパリブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ニラパリブのアメリカ市場規模推移 ・ニラパリブのカナダ市場規模推移 ・ニラパリブのメキシコ市場規模推移 ・ニラパリブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ニラパリブのドイツ市場規模推移 ・ニラパリブのイギリス市場規模推移 ・ニラパリブのロシア市場規模推移 ・ニラパリブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ニラパリブの日本市場規模推移 ・ニラパリブの中国市場規模推移 ・ニラパリブの韓国市場規模推移 ・ニラパリブのインド市場規模推移 ・ニラパリブの東南アジア市場規模推移 ・ニラパリブの南米市場分析（ブラジル、アルゼンチン等） ・ニラパリブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ニラパリブの種類別分析/販売量、売上、市場シェア（100mg * 30カプセル、100mg * 60カプセル、100mg * 90カプセル） ・ニラパリブの用途別分析/市場規模（再発上皮性卵巣癌、卵管癌、原発性腹膜癌、その他） ・ニラパリブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ニラパリブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Niraparib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Niraparib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
TESARO
Everest Pharmaceuticals Limited
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
100mg*30 Capsules
100mg*60 Capsules
100mg*90 Capsules
Market Segment by Applications, can be divided into
Recurrent Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Niraparib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Niraparib, with price, sales, revenue and global market share of Niraparib in 2017 and 2018.
Chapter 3, the Niraparib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Niraparib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Niraparib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Niraparib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Niraparib Introduction
1.2 Market Analysis by Type
1.2.1 100mg*30 Capsules
1.2.2 100mg*60 Capsules
1.2.3 100mg*90 Capsules
1.3 Market Analysis by Applications
1.3.1 Recurrent Epithelial Ovarian Cancer
1.3.2 Fallopian Tube Cancer
1.3.3 Primary Peritoneal Cancer
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 TESARO
2.1.1 Business Overview
2.1.2 Niraparib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 TESARO Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Everest Pharmaceuticals Limited
2.2.1 Business Overview
2.2.2 Niraparib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Everest Pharmaceuticals Limited Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Niraparib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Niraparib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Niraparib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Niraparib Manufacturer Market Share in 2018
3.3.2 Top 6 Niraparib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Niraparib Market Analysis by Regions
4.1 Global Niraparib Sales, Revenue and Market Share by Regions
4.1.1 Global Niraparib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Niraparib Revenue and Market Share by Regions (2014-2019)
4.2 North America Niraparib Sales and Growth Rate (2014-2019)
4.3 Europe Niraparib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Niraparib Sales and Growth Rate (2014-2019)
4.5 South America Niraparib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Niraparib Sales and Growth Rate (2014-2019)
5 North America Niraparib by Country
5.1 North America Niraparib Sales, Revenue and Market Share by Country
5.1.1 North America Niraparib Sales and Market Share by Country (2014-2019)
5.1.2 North America Niraparib Revenue and Market Share by Country (2014-2019)
5.2 United States Niraparib Sales and Growth Rate (2014-2019)
5.3 Canada Niraparib Sales and Growth Rate (2014-2019)
5.4 Mexico Niraparib Sales and Growth Rate (2014-2019)
6 Europe Niraparib by Country
6.1 Europe Niraparib Sales, Revenue and Market Share by Country
6.1.1 Europe Niraparib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Niraparib Revenue and Market Share by Country (2014-2019)
6.2 Germany Niraparib Sales and Growth Rate (2014-2019)
6.3 UK Niraparib Sales and Growth Rate (2014-2019)
6.4 France Niraparib Sales and Growth Rate (2014-2019)
6.5 Russia Niraparib Sales and Growth Rate (2014-2019)
6.6 Italy Niraparib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Niraparib by Country
7.1 Asia-Pacific Niraparib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Niraparib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Niraparib Revenue and Market Share by Country (2014-2019)
7.2 China Niraparib Sales and Growth Rate (2014-2019)
7.3 Japan Niraparib Sales and Growth Rate (2014-2019)
7.4 Korea Niraparib Sales and Growth Rate (2014-2019)
7.5 India Niraparib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Niraparib Sales and Growth Rate (2014-2019)
8 South America Niraparib by Country
8.1 South America Niraparib Sales, Revenue and Market Share by Country
8.1.1 South America Niraparib Sales and Market Share by Country (2014-2019)
8.1.2 South America Niraparib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Niraparib Sales and Growth Rate (2014-2019)
8.3 Argentina Niraparib Sales and Growth Rate (2014-2019)
8.4 Colombia Niraparib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Niraparib by Countries
9.1 Middle East and Africa Niraparib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Niraparib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Niraparib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Niraparib Sales and Growth Rate (2014-2019)
9.3 Turkey Niraparib Sales and Growth Rate (2014-2019)
9.4 Egypt Niraparib Sales and Growth Rate (2014-2019)
9.5 Nigeria Niraparib Sales and Growth Rate (2014-2019)
9.6 South Africa Niraparib Sales and Growth Rate (2014-2019)
10 Global Niraparib Market Segment by Type
10.1 Global Niraparib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Niraparib Sales and Market Share by Type (2014-2019)
10.1.2 Global Niraparib Revenue and Market Share by Type (2014-2019)
10.2 100mg*30 Capsules Sales Growth and Price
10.2.1 Global 100mg*30 Capsules Sales Growth (2014-2019)
10.2.2 Global 100mg*30 Capsules Price (2014-2019)
10.3 100mg*60 Capsules Sales Growth and Price
10.3.1 Global 100mg*60 Capsules Sales Growth (2014-2019)
10.3.2 Global 100mg*60 Capsules Price (2014-2019)
10.4 100mg*90 Capsules Sales Growth and Price
10.4.1 Global 100mg*90 Capsules Sales Growth (2014-2019)
10.4.2 Global 100mg*90 Capsules Price (2014-2019)
11 Global Niraparib Market Segment by Application
11.1 Global Niraparib Sales Market Share by Application (2014-2019)
11.2 Recurrent Epithelial Ovarian Cancer Sales Growth (2014-2019)
11.3 Fallopian Tube Cancer Sales Growth (2014-2019)
11.4 Primary Peritoneal Cancer Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Niraparib Market Forecast (2019-2024)
12.1 Global Niraparib Sales, Revenue and Growth Rate (2019-2024)
12.2 Niraparib Market Forecast by Regions (2019-2024)
12.2.1 North America Niraparib Market Forecast (2019-2024)
12.2.2 Europe Niraparib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Niraparib Market Forecast (2019-2024)
12.2.4 South America Niraparib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Niraparib Market Forecast (2019-2024)
12.3 Niraparib Market Forecast by Type (2019-2024)
12.3.1 Global Niraparib Sales Forecast by Type (2019-2024)
12.3.2 Global Niraparib Market Share Forecast by Type (2019-2024)
12.4 Niraparib Market Forecast by Application (2019-2024)
12.4.1 Global Niraparib Sales Forecast by Application (2019-2024)
12.4.2 Global Niraparib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Niraparib Picture
Table Product Specifications of Niraparib
Figure Global Sales Market Share of Niraparib by Types in 2018
Table Niraparib Types for Major Manufacturers
Figure 100mg*30 Capsules Picture
Figure 100mg*60 Capsules Picture
Figure 100mg*90 Capsules Picture
Figure Niraparib Sales Market Share by Applications in 2018
Figure Recurrent Epithelial Ovarian Cancer Picture
Figure Fallopian Tube Cancer Picture
Figure Primary Peritoneal Cancer Picture
Figure Other Picture
Figure United States Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure France Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure China Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure India Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Niraparib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Niraparib Revenue (Value) and Growth Rate (2014-2024)
Table TESARO Basic Information, Manufacturing Base and Competitors
Table TESARO Niraparib Type and Applications
Table TESARO Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Everest Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table Everest Pharmaceuticals Limited Niraparib Type and Applications
Table Everest Pharmaceuticals Limited Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Niraparib Sales by Manufacturer (2017-2018)
Figure Global Niraparib Sales Market Share by Manufacturer in 2017
Figure Global Niraparib Sales Market Share by Manufacturer in 2018
Table Global Niraparib Revenue by Manufacturer (2017-2018)
Figure Global Niraparib Revenue Market Share by Manufacturer in 2017
Figure Global Niraparib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Niraparib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Niraparib Manufacturer (Revenue) Market Share in 2018
Figure Global Niraparib Sales and Growth Rate (2014-2019)
Figure Global Niraparib Revenue and Growth Rate (2014-2019)
Table Global Niraparib Sales by Regions (2014-2019)
Table Global Niraparib Sales Market Share by Regions (2014-2019)
Table Global Niraparib Revenue by Regions (2014-2019)
Figure Global Niraparib Revenue Market Share by Regions (2014-2019)
Figure Global Niraparib Revenue Market Share by Regions in 2018
Figure North America Niraparib Sales and Growth Rate (2014-2019)
Figure Europe Niraparib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Niraparib Sales and Growth Rate (2014-2019)
Figure South America Niraparib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Niraparib Sales and Growth Rate (2014-2019)
Figure North America Niraparib Revenue and Growth Rate (2014-2019)
Table North America Niraparib Sales by Countries (2014-2019)
Table North America Niraparib Sales Market Share by Countries (2014-2019)
Figure North America Niraparib Sales Market Share by Countries (2014-2019)
Figure North America Niraparib Sales Market Share by Countries in 2018
Table North America Niraparib Revenue by Countries (2014-2019)
Table North America Niraparib Revenue Market Share by Countries (2014-2019)
Figure North America Niraparib Revenue Market Share by Countries (2014-2019)
Figure North America Niraparib Revenue Market Share by Countries in 2018
Figure United States Niraparib Sales and Growth Rate (2014-2019)
Figure Canada Niraparib Sales and Growth Rate (2014-2019)
Figure Mexico Niraparib Sales and Growth Rate (2014-2019)
Figure Europe Niraparib Revenue and Growth Rate (2014-2019)
Table Europe Niraparib Sales by Countries (2014-2019)
Table Europe Niraparib Sales Market Share by Countries (2014-2019)
Table Europe Niraparib Revenue by Countries (2014-2019)
Figure Europe Niraparib Revenue Market Share by Countries (2014-2019)
Figure Europe Niraparib Revenue Market Share by Countries in 2018
Figure Germany Niraparib Sales and Growth Rate (2014-2019)
Figure UK Niraparib Sales and Growth Rate (2014-2019)
Figure France Niraparib Sales and Growth Rate (2014-2019)
Figure Russia Niraparib Sales and Growth Rate (2014-2019)
Figure Italy Niraparib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Niraparib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Niraparib Sales by Countries (2014-2019)
Table Asia-Pacific Niraparib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Niraparib Sales Market Share by Countries 2018
Table Asia-Pacific Niraparib Revenue by Countries (2014-2019)
Figure Asia-Pacific Niraparib Revenue Market Share by Countries 2018
Figure China Niraparib Sales and Growth Rate (2014-2019)
Figure Japan Niraparib Sales and Growth Rate (2014-2019)
Figure Korea Niraparib Sales and Growth Rate (2014-2019)
Figure India Niraparib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Niraparib Sales and Growth Rate (2014-2019)
Figure South America Niraparib Revenue and Growth Rate (2014-2019)
Table South America Niraparib Sales by Countries (2014-2019)
Table South America Niraparib Sales Market Share by Countries (2014-2019)
Figure South America Niraparib Sales Market Share by Countries in 2018
Table South America Niraparib Revenue by Countries (2014-2019)
Table South America Niraparib Revenue Market Share by Countries (2014-2019)
Figure South America Niraparib Revenue Market Share by Countries in 2018
Figure Brazil Niraparib Sales and Growth Rate (2014-2019)
Figure Argentina Niraparib Sales and Growth Rate (2014-2019)
Figure Colombia Niraparib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Niraparib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Niraparib Sales by Countries (2014-2019)
Table Middle East and Africa Niraparib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Niraparib Sales Market Share by Countries in 2018
Table Middle East and Africa Niraparib Revenue by Countries (2014-2019)
Table Middle East and Africa Niraparib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Niraparib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Niraparib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Niraparib Sales and Growth Rate (2014-2019)
Figure UAE Niraparib Sales and Growth Rate (2014-2019)
Figure Egypt Niraparib Sales and Growth Rate (2014-2019)
Figure Nigeria Niraparib Sales and Growth Rate (2014-2019)
Figure South Africa Niraparib Sales and Growth Rate (2014-2019)
Table Global Niraparib Sales by Type (2014-2019)
Table Global Niraparib Sales Share by Type (2014-2019)
Table Global Niraparib Revenue by Type (2014-2019)
Table Global Niraparib Revenue Share by Type (2014-2019)
Figure Global 100mg*30 Capsules Sales Growth (2014-2019)
Figure Global 100mg*30 Capsules Price (2014-2019)
Figure Global 100mg*60 Capsules Sales Growth (2014-2019)
Figure Global 100mg*60 Capsules Price (2014-2019)
Figure Global 100mg*90 Capsules Sales Growth (2014-2019)
Figure Global 100mg*90 Capsules Price (2014-2019)
Table Global Niraparib Sales by Application (2014-2019)
Table Global Niraparib Sales Share by Application (2014-2019)
Figure Global Fallopian Tube Cancer Sales Growth (2014-2019)
Figure Global Primary Peritoneal Cancer Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Niraparib Sales, Revenue and Growth Rate (2019-2024)
Table Global Niraparib Sales Forecast by Regions (2019-2024)
Table Global Niraparib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Niraparib Market Forecast (2019-2024)
Figure Europe Sales Niraparib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Niraparib Market Forecast (2019-2024)
Figure South America Sales Niraparib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Niraparib Market Forecast (2019-2024)
Table Global Niraparib Sales Forecast by Type (2019-2024)
Table Global Niraparib Market Share Forecast by Type (2019-2024)
Table Global Niraparib Sales Forecast by Application (2019-2024)
Table Global Niraparib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
ニネタニブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Nintedanib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Nintedanib in global market,…- 世界の腹膜がん市場：市場規模・現状・予測 Peritoneal cancer is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma and psammomacarcinoma.Peritoneal cancer develops in a thin layer of tissue that lines the abdomen. It also covers the uterus, bladde…
- アンロチニブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Anlotinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Anlotinib in global market, e…
- 吸入カプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Inhalation Capsules are used to deliver medical powders to the human lung with a special device. Designed as functional capsules, Inhalation capsules contain less than 5% residue of medicine on the inner wall of the capsule, thus enhancing the efficacy of the medicine taken. Scope of the Report: The…
- 蒸気カプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Vapor Capsules is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Vapor Capsules in global…